UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 100

Sortiert nach

NK-92: an ‘off-the-shelf therapeutic’ for adoptive natural killer cell-based cancer immunotherapy

Cancer Immunology, Immunotherapy, 2016-04, Vol.65 (4), p.485-492

2016

Volltextzugriff (PDF)

Selective Inhibition of Tumor Growth by Clonal NK Cells Expressing an ErbB2/HER2-Specific Chimeric Antigen Receptor

Molecular therapy, 2015-02, Vol.23 (2), p.330-338

2015

Volltextzugriff (PDF)

Inability of granule polarization by NK cells defines tumor resistance and can be overcome by CAR or ADCC mediated targeting

Journal for immunotherapy of cancer, 2021-01, Vol.9 (1), p.e001334

2021

Volltextzugriff (PDF)

Treatment of patients with advanced cancer with the natural killer cell line NK-92

Cytotherapy (Oxford, England), 2013-12, Vol.15 (12), p.1563-1570

2013

Volltextzugriff (PDF)

Cellular therapy of cancer with natural killer cells—where do we stand?

Cytotherapy (Oxford, England), 2013-10, Vol.15 (10), p.1185-1194

Klingemann, Hans G

2013

Volltextzugriff (PDF)

Clinicopathological Significance of Major Histocompatibility Complex Class I-Related Chain A and B Expression in Thyroid Cancer

The journal of clinical endocrinology and metabolism, 2006-07, Vol.91 (7), p.2704-2712

2006

Volltextzugriff (PDF)

Allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning in intermediate- or high-risk patients with myelofibrosis with myeloid metaplasia

Blood, 2005-05, Vol.105 (10), p.4115-4119

2005

Volltextzugriff (PDF)

Identification of CD19 and CD20 Peptides for Induction of Antigen-Specific CTLs against B-Cell Malignancies

Clinical cancer research, 2005-02, Vol.11 (4), p.1629-1638

2005

Volltextzugriff (PDF)

Heteroclitic CD33 Peptide With Enhanced Anti-Acute Myeloid Leukemic Immunogenicity

Clinical cancer research, 2004-10, Vol.10 (20), p.7043-7052

2004

Volltextzugriff (PDF)

Hematopoietic stem cell transplantation: bone marrow vs. mobilized peripheral blood

Archives of Medical Research, 2003-11, Vol.34 (6), p.545-553

2003

Volltextzugriff (PDF)

Role of immunotherapy in stem cell transplantation

International journal of hematology, 2003, Vol.77 (1), p.22-28

2003

Volltextzugriff (PDF)

Natural killer: can they be useful as adoptive immunotherapy for cancer?

Expert opinion on biological therapy, 2005-02, Vol.5 (2), p.163-172

2005

Volltextzugriff (PDF)

Cytogenetic Abnormalities in Primary Myelodysplastic Syndrome Are Highly Predictive of Outcome After Allogeneic Bone Marrow Transplantation

Blood, 1998-09, Vol.92 (6), p.1910-1917

1998

Volltextzugriff (PDF)

The effect of LIGHT in inducing maturation of monocyte-derived dendritic cells from MDS patients

Cancer Immunology, Immunotherapy, 2004-08, Vol.53 (8), p.681-689

2004

Volltextzugriff (PDF)

Identification of novel CD33 antigen-specific peptides for the generation of cytotoxic T lymphocytes against acute myeloid leukemia

Cellular immunology, 2004, Vol.227 (1), p.38-50

2004

Volltextzugriff (PDF)

Mechanical ventilation for bone marrow transplant patients: When does it become futile?

Critical care medicine, 2000-03, Vol.28 (3), p.899-900

Klingemann, Hans G

2000

Volltextzugriff (PDF)

Natural killer cell-based immunotherapeutic strategies

Cytotherapy (Oxford, England), 2005-03, Vol.7 (1), p.16-22

Klingemann, H.-G.

2005

Volltextzugriff (PDF)

Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells

Leukemia, 1994-04, Vol.8 (4), p.652-658

1994

Volltextzugriff (PDF)

A Phase II, Safety and Efficacy Study of Fixed Dose Radioimmunotherapy (Zevalin, yttrium-90 ibritumomab tiuxetan) for Patients with Incomplete Response to Chemotherapy Prior to Autologous Stem Cell Transplant (ASCT) for Multiple Myeloma

Biology of blood and marrow transplantation, 2015-02, Vol.21 (2), p.S199-S199

2015

Volltextzugriff (PDF)

Use of the Anti-idiotype Breast Cancer Vaccine 11D10 in Conjunction with Autologous Stem Cell Transplantation in Patients with Metastatic Breast Cancer

Clinical breast cancer, 2003-02, Vol.3, p.S152-S157

2003

Volltextzugriff (PDF)

Mini-transplants turning micro: how low can we go?

Journal of hematotherapy & stem cell research, 2002-12, Vol.11 (6), p.859-862

Klingemann, Hans-G

2002

Volltextzugriff (PDF)

Ex vivo expansion of the highly cytotoxic human natural killer cell line NK-92 under current good manufacturing practice conditions for clinical adoptive cellular immunotherapy

Cytotherapy (Oxford, England), 2003, Vol.5 (3), p.259-272

2003

Volltextzugriff (PDF)

STI-stop transplanting immediately?

Journal of hematotherapy & stem cell research, 2002-04, Vol.11 (2), p.165-167

Klingemann, Hans-G

2002

Volltextzugriff (PDF)

Factors regulating the cytotoxic activity of the human natural killer cell line, NK-92

Journal of hematotherapy & stem cell research, 2001-06, Vol.10 (3), p.369-383

2001

Volltextzugriff (PDF)

Transfer of the Tumor Necrosis Factor α Gene Into Hematopoietic Progenitor Cells as a Model for Site-Specific Cytokine Delivery After Marrow Transplantation

Blood, 1994-11, Vol.84 (9), p.2966-2970

1994

Volltextzugriff (PDF)

1 – 25 von 100

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(72)
Mit Volltextzugriff
(88)

Publikationsform

Sprache

Englisch
(97)
Japanisch
(18)
Deutsch
(3)

Erscheinungsjahr

n.n

Thema

Humans
(73)
Life Sciences & Biomedicine
(60)
Science & Technology
(60)
Hematology
(36)
Biological And Medical Sciences
(33)
Medical Sciences
(29)
Female
(28)
Male
(27)
Adult
(25)
Middle Aged
(25)
Medicine, Research & Experimental
(22)
Research & Experimental Medicine
(22)
Immunotherapy
(18)
Oncology
(18)
Bone Marrow Transplantation
(16)
Animals
(15)
Killer Cells, Natural - Immunology
(15)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(14)
Transfusions. Complications. Transfusion Reactions. Cell And Gene Therapy
(14)
Transplantation
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

NK-92: an ‘off-the-shelf therapeutic’ for adoptive natural killer cell-based cancer immunotherapy

Selective Inhibition of Tumor Growth by Clonal NK Cells Expressing an ErbB2/HER2-Specific Chimeric Antigen Receptor

Inability of granule polarization by NK cells defines tumor resistance and can be overcome by CAR or ADCC mediated targeting

Treatment of patients with advanced cancer with the natural killer cell line NK-92

Cellular therapy of cancer with natural killer cells—where do we stand?

Clinicopathological Significance of Major Histocompatibility Complex Class I-Related Chain A and B Expression in Thyroid Cancer

Allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning in intermediate- or high-risk patients with myelofibrosis with myeloid metaplasia

Identification of CD19 and CD20 Peptides for Induction of Antigen-Specific CTLs against B-Cell Malignancies

Heteroclitic CD33 Peptide With Enhanced Anti-Acute Myeloid Leukemic Immunogenicity

Hematopoietic stem cell transplantation: bone marrow vs. mobilized peripheral blood

Role of immunotherapy in stem cell transplantation

Natural killer: can they be useful as adoptive immunotherapy for cancer?

Cytogenetic Abnormalities in Primary Myelodysplastic Syndrome Are Highly Predictive of Outcome After Allogeneic Bone Marrow Transplantation

The effect of LIGHT in inducing maturation of monocyte-derived dendritic cells from MDS patients

Identification of novel CD33 antigen-specific peptides for the generation of cytotoxic T lymphocytes against acute myeloid leukemia

Mechanical ventilation for bone marrow transplant patients: When does it become futile?

Natural killer cell-based immunotherapeutic strategies

Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells

A Phase II, Safety and Efficacy Study of Fixed Dose Radioimmunotherapy (Zevalin, yttrium-90 ibritumomab tiuxetan) for Patients with Incomplete Response to Chemotherapy Prior to Autologous Stem Cell Transplant (ASCT) for Multiple Myeloma

Use of the Anti-idiotype Breast Cancer Vaccine 11D10 in Conjunction with Autologous Stem Cell Transplantation in Patients with Metastatic Breast Cancer

Mini-transplants turning micro: how low can we go?

Ex vivo expansion of the highly cytotoxic human natural killer cell line NK-92 under current good manufacturing practice conditions for clinical adoptive cellular immunotherapy

STI-stop transplanting immediately?

Factors regulating the cytotoxic activity of the human natural killer cell line, NK-92

Transfer of the Tumor Necrosis Factor α Gene Into Hematopoietic Progenitor Cells as a Model for Site-Specific Cytokine Delivery After Marrow Transplantation

Suchergebnisse filtern